Data / New clinical trials / Weight Loss
New Weight Loss clinical trials: 260 posted since Nov 2024
The full list. New Weight Loss clinical trials: 260 rows for $13, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 14 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/weight-loss, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
260 clinical studies in Weight Loss were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 55 have an industry sponsor and 156 are recruiting or about to. The newest, NCT07926152, was posted on November 9, 2026: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (German Diabetes Center).
The request: Every new Weight Loss clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 260New trials
- 55Industry sponsored
- 156Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 260, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926152 | Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes | German Diabetes Center | Not applicable | Not yet recruiting | Type 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia | 94 | Germany | clinicaltrials.gov |
| November 3, 2026 | NCT07913685 | The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight... | Medical University of Bialystok | Phase 4 | Completed | Obesity & Overweight | 83 | Poland | clinicaltrials.gov |
| November 3, 2026 | NCT07912255 | Intermittent Fasting and Anthropometric Parameters | Masaryk University | Not applicable | Completed | Intermittent Fasting, Body Weight, and Body Composition | 95 | Czechia | clinicaltrials.gov |
| November 2, 2026 | NCT07911150 | Gut-Liver-Muscle Axis in Cancer Cachexia | University of Colorado, Denver | Not applicable | Not yet recruiting | Head & Neck Cancer | 20 | United States | clinicaltrials.gov |
| November 2, 2026 | NCT07911046 | Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity | Erin Mauney | Observational | Not yet recruiting | Pediatric Obesity, Obesity | 12 | United States | clinicaltrials.gov |
| November 2, 2026 | NCT07909889 | Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer | Aarhus University Hospital | Phase 2 | Not yet recruiting | Breast Cancer (Early Breast Cancer), Obesity | 32 | Denmark | clinicaltrials.gov |
| October 28, 2026 | NCT07901777 | Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity | Yuzuncu Yil University | Observational | Recruiting | Obesity & Overweight | 200 | Turkey (Türkiye) | clinicaltrials.gov |
| October 28, 2026 | NCT07900178 | Sustaining Health After an Intensive Weight-loss Pro-gramme | Copenhagen University Hospital, Hvidovre | Observational | Enrolling by invitation | Obesity & Overweight, Weight Loss, Weight Management in Adult Patients With Obesity or Overweight | 150 | Denmark | clinicaltrials.gov |
| October 28, 2026 | NCT07900074 | Mechanisms of Weight Loss: Tirzepatide vs Semaglutide | McMaster University | Phase 4 | Recruiting | Obesity (Disorder) | 80 | Canada | clinicaltrials.gov |
| October 27, 2026 | NCT07897890 | Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care | Indiana University | Not applicable | Completed | Obesity & Overweight, Breast Cancer | 12 | United States | clinicaltrials.gov |
| October 27, 2026 | NCT07897383 | Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity | University Hospital, Gentofte, Copenhagen | Phase 1/2 | Not yet recruiting | Obesity & Overweight | 18 | clinicaltrials.gov | |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | Argentina, United States | clinicaltrials.gov |
| October 22, 2026 | NCT07888075 | Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or... | AVEO Pharmaceuticals, Inc. | Phase 2/3 | Not yet recruiting | Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell... | 950 | clinicaltrials.gov | |
| October 20, 2026 | NCT07883018 | 15-years Outcomes of Sleeve Gastrectomy on Weight Loss | Centre Hospitalier Universitaire, Amiens | Observational | Recruiting | Bariatric Surgery, Sleeve Gastrectomy, Weight Loss | 300 | France | clinicaltrials.gov |
| October 19, 2026 | NCT07880691 | Weight Loss and Comorbidity Outcomes After Revisional Bariatric Surgery | Kasr El Aini Hospital | Observational | Completed | Obesity, Morbid, Weight Regain After Bariatric Surgery, Insufficient Weight Loss After Bariatric Surgery, Complication... | 96 | clinicaltrials.gov | |
| October 15, 2026 | NCT07874633 | A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight | 432 | China | clinicaltrials.gov |
| October 13, 2026 | NCT07869758 | Gastric On in Obesity Management: Evaluation of the Safety and Efficacy of the 6-Month Gastric Balloon (Prospective) | Rigicon, Inc. | Not applicable | Completed | Obesity & Overweight | 42 | Turkey (Türkiye) | clinicaltrials.gov |
| October 9, 2026 | NCT07869290 | Benefits of Nutritional Supplement in Cancer Care | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Nutritional Deterioration, Malignant Solid Tumor, Cancer Cachexia, Cancer Malnutrition, Weight Loss, Oral Nutritional... | 100 | clinicaltrials.gov | |
| October 9, 2026 | NCT07868939 | Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) | Viking Therapeutics, Inc. | Phase 3 | Not yet recruiting | Weight Loss | 560 | clinicaltrials.gov | |
| October 9, 2026 | NCT07868835 | Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) | Viking Therapeutics, Inc. | Phase 3 | Not yet recruiting | Weight Loss | 560 | clinicaltrials.gov | |
| October 8, 2026 | NCT07866183 | Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study | National Medical Research Center for Therapy and Preventive Medicine | Not applicable | Recruiting | Class I Obesity | 120 | Russia | clinicaltrials.gov |
| October 1, 2026 | NCT07851714 | Metabolism and Nutrition in MND | Guy's and St Thomas' NHS Foundation Trust | Observational | Not yet recruiting | Amyotrophic Lateral Sclerosis (ALS), Motor Neurone Disease (MND) | 12 | United Kingdom | clinicaltrials.gov |
| September 30, 2026 | NCT07850531 | Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported Communities | Prairie View A&M University | Not applicable | Not yet recruiting | Obesity & Overweight, Prediabetes | 100 | United States | clinicaltrials.gov |
| September 29, 2026 | NCT07846865 | Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea | Woolcock Institute of Medical Research | Phase 2/3 | Not yet recruiting | Sleep Apnoea, Obesity & Overweight, Sleep Apnea Syndrome, Obstructive | 256 | Australia | clinicaltrials.gov |
| September 29, 2026 | NCT07846033 | A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities | Viking Therapeutics, Inc. | Phase 1 | Recruiting | Obese Adults | 56 | United States | clinicaltrials.gov |
| September 28, 2026 | NCT07844330 | Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese Adolescents | Centre Hospitalier Emile Roux | Not applicable | Not yet recruiting | Weight Gain, Weight Loss, Eating Attitudes, Obese Adolescents | 18 | France | clinicaltrials.gov |
| September 24, 2026 | NCT07838740 | A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities | Viking Therapeutics, Inc. | Phase 1 | Recruiting | Obese Adults | 270 | United States | clinicaltrials.gov |
| September 21, 2026 | NCT07830329 | Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or... | Regeneron Pharmaceuticals | Phase 2 | Not yet recruiting | Hidradenitis Suppurativa | 300 | clinicaltrials.gov | |
| September 21, 2026 | NCT07830121 | Very-Low-Carbohydrate Diet for Prediabetes and Obesity | Universiti Teknologi Mara | Not applicable | Completed | Prediabetes, Obesity / Overweight, VERY LOW CARBOHYDRATE DIET | 33 | Malaysia | clinicaltrials.gov |
| September 17, 2026 | NCT07824895 | Mazdutide for Weight Management and Gout in Adults With Obesity | Hongwei Jiang | Phase 4 | Not yet recruiting | Gout, Obesity (BMI>30), Hyperuricemia, Metabolic Syndrome | 30 | clinicaltrials.gov | |
| September 16, 2026 | NCT07821554 | Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma | Inna Chen, MD | Not applicable | Not yet recruiting | Pancreatic Cancer | 250 | Denmark, Italy, Norway, Romania, Spain | clinicaltrials.gov |
| September 15, 2026 | NCT07820358 | Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer | The Methodist Hospital Research Institute | Phase 2 | Not yet recruiting | Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial... | 48 | United States | clinicaltrials.gov |
| September 14, 2026 | NCT07818005 | Retrospective Continuous Glucose Monitor (CGM) Study on Glycemic Response and Body Composition in College Students | He Eye Hospital | Observational | Completed | Overweight , Obesity, Weight Loss | 59 | China | clinicaltrials.gov |
| September 11, 2026 | NCT07815236 | Diabetes Prevention Through Genetics, Familial History and Behavior Change | Morehouse School of Medicine | Phase 2/3 | Not yet recruiting | Prediabetes, Weight Loss | 400 | clinicaltrials.gov | |
| September 10, 2026 | NCT07813429 | Changes in Cervical Posture, Cervical Function, and Neck Pain After Sleeve Gastrectomy | Haydarpasa Numune Training and Research Hospital | Observational | Recruiting | Morbid Obesity Requiring Bariatric Surgery, Neck Pain Musculoskeletal | 25 | Turkey (Türkiye) | clinicaltrials.gov |
| September 9, 2026 | NCT07808723 | Georgia CEAL RESTORES Family Diabetes Study | Morehouse School of Medicine | Not applicable | Recruiting | Weight Reduction, Prediabetes | 120 | United States | clinicaltrials.gov |
| September 3, 2026 | NCT07803185 | Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists | TC Erciyes University | Observational | Recruiting | Obesity, Emotional Eating, Anhedonia | 60 | Turkey (Türkiye) | clinicaltrials.gov |
| September 1, 2026 | NCT07796789 | Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma | Sun Yat-sen University | Phase 3 | Recruiting | Nasopharyngeal Cancinoma (NPC) | 204 | China | clinicaltrials.gov |
| September 1, 2026 | NCT07796503 | TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric Bypass | National Scientific Center of Surgery named after A.N.Syzganov | Not applicable | Recruiting | Morbid Obesity, Obesity | 100 | Kazakhstan | clinicaltrials.gov |
| August 31, 2026 | NCT07794566 | Longitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A... | Marmara University | Observational | Active not recruiting | Obese, Limb Deformities, Arthritis | 30 | Turkey (Türkiye) | clinicaltrials.gov |
| August 31, 2026 | NCT07794553 | Longitudinal Changes in Spinopelvic Alignment and Sagittal Balance After Bariatric Surgery in Patients With Morbid Obesity: A Prospective... | Marmara University | Observational | Active not recruiting | Obesity, Spine Condition | 30 | Turkey (Türkiye) | clinicaltrials.gov |
| August 28, 2026 | NCT07792954 | A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight | 300 | China | clinicaltrials.gov |
| August 27, 2026 | NCT07789223 | Weight and Metabolic Management Study | Elenzia | Not applicable | Recruiting | Overweight, Obesity, Weight Maintenance | 200 | United Kingdom | clinicaltrials.gov |
| August 21, 2026 | NCT07778550 | Effects of Diet, Exercise, and Electrical Muscle Stimulation in Overweight and Obese Women | Dicle University | Not applicable | Completed | Obesity & Overweight | 75 | Turkey (Türkiye) | clinicaltrials.gov |
| August 20, 2026 | NCT07777575 | Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide | Technical University of Munich | Phase 4 | Recruiting | Obesity (BMI>30) | 150 | Germany | clinicaltrials.gov |
| August 20, 2026 | NCT07775404 | A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity, Overweight | 351 | China, Hong Kong, Malaysia, Philippines, Thailand | clinicaltrials.gov |
| August 19, 2026 | NCT07774208 | FABP4 Response After Roux-en-Y Gastric Bypass | Istanbul University | Observational | Completed | Obesity (BMI>30), Obesity (BMI > 35), Insulin Resistance, Bariatric Surgery, Bariatric Surgery (Gastric Bypass) | 28 | clinicaltrials.gov | |
| August 18, 2026 | NCT07770893 | Acupoint Catgut Embedding With Laser Acupuncture for Weight Loss in Adults With Obesity | Taipei City Hospital | Not applicable | Not yet recruiting | Obesity, Obesity, Abdominal, Overweight | 120 | Taiwan | clinicaltrials.gov |
| August 11, 2026 | NCT07758387 | Polydextrose Functional Gummies for Weight Management in Adults With Overweight or Obesity | Nutris We Care About You S.L. | Not applicable | Not yet recruiting | Obesity & Overweight | 96 | Spain | clinicaltrials.gov |
| July 31, 2026 | NCT07739095 | Weight Loss and Hunger | University of Ottawa | Not applicable | Not yet recruiting | Obesity & Overweight | 40 | Canada | clinicaltrials.gov |
| July 31, 2026 | NCT07738276 | Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart... | Shahid Beheshti University of Medical Sciences | Phase 3 | Not yet recruiting | Heart Failure and Reduced Ejection Fraction, Obesity & Overweight, Tirzepatide | 60 | clinicaltrials.gov | |
| July 30, 2026 | NCT07736547 | AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss | Varol TUNALI | Not applicable | Enrolling by invitation | Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25) | 80 | Turkey (Türkiye) | clinicaltrials.gov |
| July 24, 2026 | NCT07724431 | A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and... | HongKong Curegene Innovation Co., Limited | Phase 1 | Not yet recruiting | Overweight and Obesity | 64 | Australia | clinicaltrials.gov |
| July 22, 2026 | NCT07720414 | Effects of GLP-1 RAs on Human Lactation Outcomes | University of Colorado, Denver | Observational | Recruiting | Lactation, Weight Loss | 18 | United States | clinicaltrials.gov |
| July 22, 2026 | NCT07718516 | Feasibility and Validation of a Smart Changing Pad for Home Infant Weight Monitoring After Hospital Discharge | Stan Kachnowski | Not applicable | Completed | Infant Nutrition Disorders, Weight Loss, Postnatal Care, Premature Birth | 12 | United States | clinicaltrials.gov |
| July 14, 2026 | NCT07703358 | Effect of Chromium Weight Reduction on Adult Asthma Control | Cairo University | Not applicable | Not yet recruiting | Asthma Chronic, Bronchial Asthma | 60 | clinicaltrials.gov | |
| July 14, 2026 | NCT07702461 | Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | Ohio State University | Observational | Recruiting | Obesity & Overweight, Diabetes (DM) | 300 | United States | clinicaltrials.gov |
| July 13, 2026 | NCT07700030 | High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE) | NYU Langone Health | Not applicable | Not yet recruiting | Weight Loss | 32 | United States | clinicaltrials.gov |
| July 9, 2026 | NCT07693491 | Sleep Evaluation Before and After Metabolic Surgery | Catharina Ziekenhuis Eindhoven | Observational | Not yet recruiting | Obesity & Overweight, Obesity & Overweight Sleep, Sleep, Metabolic Surgery | 50 | Netherlands | clinicaltrials.gov |
| July 9, 2026 | NCT07693426 | Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Phase 1 | Recruiting | Adolescence Obesity | 36 | China | clinicaltrials.gov |
| July 8, 2026 | NCT07690592 | A Single-arm Pilot Feasibility Trial of Healthy Pride | University of Connecticut | Not applicable | Not yet recruiting | Obesity & Overweight | 40 | clinicaltrials.gov | |
| July 6, 2026 | NCT07685834 | Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss | Sofwave Medical LTD | Not applicable | Active not recruiting | Lax Skin | 30 | Canada | clinicaltrials.gov |
| June 30, 2026 | NCT07674875 | Meal Frequency and Timing on Metabolic Health in Patients With Type 2 Diabetes | Akdeniz University | Not applicable | Completed | Type 2 Diabetes, Obesity and Overweight | 144 | Turkey (Türkiye) | clinicaltrials.gov |
| June 23, 2026 | NCT07663942 | Targeting Sedentary Behavior Reduction and Physical Fitness Enhancement in Women Before and Beyond Bariatric Surgery- BARIMOV Study Protocol | Hospital de Sao Sebastiao | Not applicable | Recruiting | Obesity (Disorder) | 72 | Portugal | clinicaltrials.gov |
| June 23, 2026 | NCT07663630 | A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss | Pfizer | Phase 1 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC), Cachexia | 80 | China, United States | clinicaltrials.gov |
| June 18, 2026 | NCT07657286 | Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients | Badr University | Not applicable | Recruiting | Chronic Kidney Disease, Diabetes | 60 | Egypt | clinicaltrials.gov |
| June 18, 2026 | NCT07655739 | The Effects of Sleeve Gastrectomy on Fractalkine | Mehmet Buğra Bozan | Observational | Completed | Obesity & Overweight | 40 | Turkey (Türkiye) | clinicaltrials.gov |
| June 17, 2026 | NCT07654062 | Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) | Shandong Provincial Hospital | Phase 4 | Not yet recruiting | Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance (Prediabetes) | 150 | China | clinicaltrials.gov |
| June 15, 2026 | NCT07647991 | The IGBallon (R) - for Use in the Treatment of Obesity | Medical University of Vienna | Not applicable | Completed | Weight Loss, Adverse Events, Comorbidities | 5 | Austria | clinicaltrials.gov |
| June 10, 2026 | NCT07638592 | Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity | Azienda Sanitaria Locale Napoli 2 Nord | Observational | Completed | Obese Adults, Hernia Abdominal Wall, Prehabilitation | 91 | Italy | clinicaltrials.gov |
| June 9, 2026 | NCT07636395 | Eating Behaviour Before, During, and After Obesity Medication | University College Dublin | Observational | Recruiting | Obesity Type 2 Diabetes Mellitus, Obesity & Overweight | 30 | Ireland | clinicaltrials.gov |
| June 9, 2026 | NCT07636239 | Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery | Özlem ÖZPAK AKKUŞ | Observational | Not yet recruiting | Obesity, Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, Eating Behavior, Nutritional Status | 40 | Turkey (Türkiye) | clinicaltrials.gov |
| June 4, 2026 | NCT07627256 | Weight Loss Composition and Metabolic Adaptation During Hypocaloric Dieting | Tel Aviv University | Not applicable | Not yet recruiting | Obesity | 150 | clinicaltrials.gov | |
| June 2, 2026 | NCT07621640 | Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study) | Hallym University | Not applicable | Not yet recruiting | Obesity, Metabolic Syndrome, Brown Adipose Tissue | 80 | South Korea | clinicaltrials.gov |
| June 1, 2026 | NCT07616752 | The Impact of Salmon Protein Hydrolysate (SPH / ProGo®) Supplementation on Hematologic and Metabolic Health | Hofseth Biocare ASA | Not applicable | Completed | Overweight (BMI > 25), Weight Loss | 14 | India | clinicaltrials.gov |
| May 29, 2026 | NCT07614178 | Effects of a Soya-Based Fibre Beverage on Weight and Health in Overweight Adults | Universiti Sains Malaysia | Not applicable | Completed | Overweight Adults | 42 | Malaysia | clinicaltrials.gov |
| May 28, 2026 | NCT07611552 | Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications... | Huazhong University of Science and Technology | Not applicable | Not yet recruiting | Obesity & Overweight | 600 | China | clinicaltrials.gov |
| May 27, 2026 | NCT07608016 | A Study to Evaluate a Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of Life | Able Biolabs, LLC | Not applicable | Completed | Weight Loss, Metabolic Health, Quality of Life | 20 | United States | clinicaltrials.gov |
| May 22, 2026 | NCT07605169 | Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended) | Vastra Gotaland Region | Not applicable | Active not recruiting | Overweight, Obesity, Prediabetic State | 103 | Sweden | clinicaltrials.gov |
| May 22, 2026 | NCT07602803 | The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK | The Queen Elizabeth Hospital | Observational | Completed | Bardet-Biedl Syndrome | 300 | United Kingdom | clinicaltrials.gov |
| May 22, 2026 | NCT07601061 | Simplifying Diet Tracking in a Digital Weight Loss Intervention | Stanford University | Not applicable | Not yet recruiting | Overweight, Obesity, Weight Loss, Health Behavior, Lifestyle Intervention | 328 | United States | clinicaltrials.gov |
| May 18, 2026 | NCT07592546 | Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss | Alain Dagher | Phase 4 | Recruiting | Class I/II Obesity | 240 | Canada | clinicaltrials.gov |
| May 15, 2026 | NCT07588984 | GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study | Noom Inc. | Observational | Not yet recruiting | Obesity & Overweight, Weight Loss, Preventative Health, Body Weight, Cardiovascular Disease Risk Factor | 2,310 | United States | clinicaltrials.gov |
| May 14, 2026 | NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 160 | Paraguay | clinicaltrials.gov |
| May 13, 2026 | NCT07582536 | Optimization of Dietary Adherence in a Mobile Weight Loss Intervention | UNC Lineberger Comprehensive Cancer Center | Not applicable | Not yet recruiting | Overweight and/or Obesity | 580 | United States | clinicaltrials.gov |
| May 11, 2026 | NCT07577765 | Testing a Tailored Approach to Long-Term Weight Loss Success | University of Utah | Not applicable | Recruiting | Weight Loss, Weight Regain, Obesity & Overweight | 30 | United States | clinicaltrials.gov |
| May 8, 2026 | NCT07576777 | Hormonal and Microbiota Modulation After Endoscopic Sleeve Gastroplasty | Assistance Publique - Hôpitaux de Paris | Not applicable | Not yet recruiting | Obesity (Disorder), Metabolic Disorders | 40 | France | clinicaltrials.gov |
| May 6, 2026 | NCT07569172 | Improved Child Nutrition and Development Through Social Transfers | Swiss Tropical & Public Health Institute | Not applicable | Not yet recruiting | Breastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress... | 1,040 | Côte d’Ivoire | clinicaltrials.gov |
| May 5, 2026 | NCT07567937 | Effects of Exercise and Short Term Rapid Weight Loss on Whole Blood Cells and Lymphocyte Subsets in Highly Trained National Level Wrestlers | Ankara Yildirim Beyazıt University | Not applicable | Completed | Weight Loss, Exercise | 9 | Turkey (Türkiye) | clinicaltrials.gov |
| May 1, 2026 | NCT07560969 | Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans | University of Missouri, Kansas City | Not applicable | Not yet recruiting | Diabetes, Physical Activity, Food Security, Nutrition Security | 408 | United States | clinicaltrials.gov |
| May 1, 2026 | NCT07560579 | Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With... | Million Marker Wellness, Inc. | Not applicable | Active not recruiting | Obesity &Amp;Amp;Amp; Overweight, Environmental Exposure, Overweight (BMI > 25) | 226 | United States | clinicaltrials.gov |
| April 30, 2026 | NCT07558603 | Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1... | Goldman, Butterwick, Fitzpatrick and Groff | Not applicable | Not yet recruiting | Laxity; Skin | 50 | United States | clinicaltrials.gov |
| April 28, 2026 | NCT07553299 | A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With... | Verdiva Bio Dev Limited | Phase 2 | Terminated | Obesity, Overweight, Weight Maintenance | 8 | United States | clinicaltrials.gov |
| April 23, 2026 | NCT07547722 | Effect of a High-Protein Diet With Meal Replacements on Weight Loss | Kazakh Academy of Nutrition | Not applicable | Active not recruiting | Obesity & Overweight | 60 | Kazakhstan | clinicaltrials.gov |
| April 21, 2026 | NCT07541872 | Weight Loss Goals and Satisfaction Survey | Pennington Biomedical Research Center | Observational | Not yet recruiting | Overweight and Obesity | 250 | clinicaltrials.gov | |
| April 20, 2026 | NCT07540754 | A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Diabetes Mellitus, Weight Loss | 24 | China | clinicaltrials.gov |
| April 17, 2026 | NCT07535892 | Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Weight Loss, GLP - 1, Weight Loss Maintenance, Obesity & Overweight | 64 | United States | clinicaltrials.gov |
| April 16, 2026 | NCT07534254 | Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program | University of North Carolina, Chapel Hill | Not applicable | Active not recruiting | Overweight and/or Obesity | 20 | United States | clinicaltrials.gov |
| April 15, 2026 | NCT07530718 | Body Composition Outcomes in MS Patients | Pennington Biomedical Research Center | Observational | Recruiting | Obesity | 20 | United States | clinicaltrials.gov |
| April 6, 2026 | NCT07513168 | Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults | Asian Institute Of Medical Sciences | Phase 4 | Recruiting | Obesity, Weight Reduction, Cardiometabolic Risk Factors | 60 | Pakistan | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Viking Therapeutics, Inc. | 7 | October 9, 2026 |
| Pfizer | 5 | October 15, 2026 |
| University of Colorado, Denver | 4 | November 2, 2026 |
| University of Alabama at Birmingham | 4 | April 17, 2026 |
| Boston Scientific Corporation | 4 | December 11, 2025 |
| Pennington Biomedical Research Center | 3 | April 21, 2026 |
| General Committee of Teaching Hospitals and Institutes, Egypt | 3 | February 27, 2026 |
| University of Texas Southwestern Medical Center | 3 | January 23, 2026 |
| Clinica Universidad de Navarra, Universidad de Navarra | 3 | September 10, 2025 |
| BTL Industries Ltd. | 3 | April 4, 2025 |
| McMaster University | 2 | October 28, 2026 |
| Eli Lilly and Company | 2 | October 22, 2026 |
| Centre Hospitalier Universitaire, Amiens | 2 | October 20, 2026 |
| Morehouse School of Medicine | 2 | September 11, 2026 |
| Marmara University | 2 | August 31, 2026 |
| Cairo University | 2 | July 14, 2026 |
| NYU Langone Health | 2 | July 13, 2026 |
| Medical University of Vienna | 2 | June 15, 2026 |
| Tel Aviv University | 2 | June 4, 2026 |
| Vastra Gotaland Region | 2 | May 22, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 144 | November 9, 2026 |
| Observational | 46 | November 2, 2026 |
| Phase 4 | 20 | November 3, 2026 |
| Phase 2 | 18 | November 2, 2026 |
| Phase 3 | 13 | October 15, 2026 |
| Phase 1 | 12 | September 29, 2026 |
| Phase 2/3 | 6 | October 22, 2026 |
| Phase 1/2 | 1 | October 27, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 102 | November 2, 2026 |
| China | 25 | October 15, 2026 |
| Turkey (Türkiye) | 18 | October 28, 2026 |
| Canada | 11 | October 28, 2026 |
| Spain | 11 | September 16, 2026 |
| Italy | 9 | September 16, 2026 |
| France | 7 | October 20, 2026 |
| United Kingdom | 7 | October 1, 2026 |
| Egypt | 7 | June 18, 2026 |
| Germany | 6 | November 9, 2026 |
| Czechia | 4 | November 3, 2026 |
| Denmark | 4 | November 2, 2026 |
| Australia | 4 | September 29, 2026 |
| Taiwan | 4 | August 18, 2026 |
| Netherlands | 4 | July 9, 2026 |
| Poland | 3 | November 3, 2026 |
| Malaysia | 3 | September 21, 2026 |
| Norway | 3 | September 16, 2026 |
| Mexico | 3 | March 6, 2026 |
| Israel | 3 | February 17, 2026 |
| Bulgaria | 3 | August 8, 2025 |
| Switzerland | 3 | August 8, 2025 |
| Puerto Rico | 3 | August 5, 2025 |
| Romania | 2 | September 16, 2026 |
| Kazakhstan | 2 | September 1, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.